Not Yet Recruiting
Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab
NCT06172036
- Conditions
- Neoadjuvant Chemotherapy, Resectable Pancreatic Cancer
- Locations
-
Not specified